DNA sequencing specialist Illumina (NASDAQ: ILMN) saw a dramatic stock price drop last week after it released a preliminary report anticipating lower-than-expected revenue growth for Q1.In this segment from the MarketFoolery podcast, Chris Hill, Charly Travers, and Jim Mueller explain what caused the dip in Illumina's (still double-digit) growth, how the company is performing in general, and why the market had such a violent reaction to the report.A transcript follows the video.Continue reading